All posts by : Felistas

When you imagine a patient in a hospital bed you will probably picture an intravenous (IV) drip as part of the scene. Between 80% and 90% of hospital inpatients will receive an infusion of one or more intravenous fluids during their stay.

A new study has found children as young as 10 show clinical-level gaming disorder, which researchers say could affect 100,000 Australian children, with a further 350,000 at risk of smartphone addiction.

Wireless health monitoring is rapidly evolving, promising a future where breathing, heart rate, and other key metrics can be tracked passively, continuously, and without the need for wearables, such as smartwatches, fitness trackers, or other bulky medical monitors.

Softgel capsules—the smooth, easy-to-swallow form of many medications and supplements—are increasingly popular for delivering everything from vitamins to omega-3s. These capsules, made of a liquid center inside a soft, flexible shell, offer convenience and effectiveness. But they’ve also come under growing scrutiny for one surprising reason: plasticizers.

A clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa and published in the New England Journal of Medicine illustrates a powerful and efficient approach for comparing different standard treatments.

Hyponatremia, or low blood sodium concentration, is typically viewed as a symptomless condition—until recently. A research team has demonstrated that chronic hyponatremia (CHN) can directly cause anxiety-like behaviors in mice by disrupting key neurotransmitters in the brain.

The U.S. Food and Drug Administration has approved George Medicines’ Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

A growing number of firearm suicides in the United States occur outside the home, most commonly in motor vehicles, according to a study published online in JAMA Network Open.

Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e. secondary tumors—in other organs. This occurs primarily in the liver and lungs, and more rarely in the brain.

Inspired by advances in cancer therapy, a team at the Buck Institute has engineered immune cells equipped with specialized targeting devices called chimeric antigen receptors (CARs) that can distinguish and respond to tau tangles and various forms of toxic amyloid plaques, both of which are implicated in Alzheimer’s disease pathology.